Course Code: aidrug
Duration: 21 hours
Prerequisites:
  • An understanding of drug discovery and development processes
  • Experience with programming in Python
  • Familiarity with machine learning concepts

Audience

  • Pharmaceutical scientists
  • AI specialists
  • Biotech researchers
Overview:

AI-driven drug discovery is transforming the pharmaceutical industry by accelerating the identification and development of new drugs. TensorFlow is a powerful machine learning framework widely used in drug discovery. Python is the programming language of choice for implementing AI models in this field.

This instructor-led, live training (online or onsite) is aimed at advanced-level professionals who wish to leverage AI techniques to revolutionize drug discovery and development processes.

By the end of this training, participants will be able to:

  • Understand the role of AI in drug discovery and development.
  • Apply machine learning techniques to predict molecular properties and interactions.
  • Use deep learning models for virtual screening and lead optimization.
  • Integrate AI-driven approaches into the clinical trial process.

Format of the Course

  • Interactive lecture and discussion.
  • Lots of exercises and practice.
  • Hands-on implementation in a live-lab environment.

Course Customization Options

  • To request a customized training for this course, please contact us to arrange.
Course Outline:

Introduction to AI in Drug Discovery

  • Overview of traditional drug discovery processes
  • The role of AI in revolutionizing drug discovery
  • Case studies: Successful AI-driven drug discovery projects

Machine Learning in Molecular Modeling

  • Basics of molecular modeling and simulations
  • Applying machine learning to predict molecular properties
  • Building predictive models for drug-target interactions

Deep Learning for Virtual Screening

  • Introduction to deep learning techniques in drug discovery
  • Implementing deep neural networks for virtual screening
  • Case studies: AI-driven virtual screening in pharmaceutical companies

AI for Lead Optimization and Drug Design

  • Techniques for optimizing lead compounds
  • Using AI to predict ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties
  • Integrating AI into the drug design pipeline

AI in Clinical Trials

  • The role of AI in clinical trial design and management
  • Predicting patient responses and adverse effects using AI models
  • Case studies: AI applications in clinical trials

Ethical Considerations and Challenges in AI-Driven Drug Discovery

  • Ethical issues in AI applications for drug discovery
  • Challenges in data privacy, bias, and model interpretability
  • Strategies for addressing ethical and regulatory concerns

Summary and Next Steps

Sites Published:

United Arab Emirates - AI-Driven Drug Discovery and Development

Qatar - AI-Driven Drug Discovery and Development

Egypt - AI-Driven Drug Discovery and Development

Saudi Arabia - AI-Driven Drug Discovery and Development

South Africa - AI-Driven Drug Discovery and Development

Brasil - AI-Driven Drug Discovery and Development

Canada - AI-Driven Drug Discovery and Development

中国 - AI-Driven Drug Discovery and Development

香港 - AI-Driven Drug Discovery and Development

澳門 - AI-Driven Drug Discovery and Development

台灣 - AI-Driven Drug Discovery and Development

USA - AI-Driven Drug Discovery and Development

Österreich - AI-Driven Drug Discovery and Development

Schweiz - AI-Driven Drug Discovery and Development

Deutschland - AI-Driven Drug Discovery and Development

Czech Republic - AI-Driven Drug Discovery and Development

Denmark - AI-Driven Drug Discovery and Development

Estonia - AI-Driven Drug Discovery and Development

Finland - AI-Driven Drug Discovery and Development

Greece - AI-Driven Drug Discovery and Development

Magyarország - AI-Driven Drug Discovery and Development

Ireland - AI-Driven Drug Discovery and Development

Luxembourg - AI-Driven Drug Discovery and Development

Latvia - AI-Driven Drug Discovery and Development

España - AI-Driven Drug Discovery and Development

Italia - AI-Driven Drug Discovery and Development

Lithuania - AI-Driven Drug Discovery and Development

Nederland - AI-Driven Drug Discovery and Development

Norway - AI-Driven Drug Discovery and Development

Portugal - AI-Driven Drug Discovery and Development

România - AI-Driven Drug Discovery and Development

Sverige - AI-Driven Drug Discovery and Development

Türkiye - AI-Driven Drug Discovery and Development

Malta - AI-Driven Drug Discovery and Development

Belgique - AI-Driven Drug Discovery and Development

France - AI-Driven Drug Discovery and Development

日本 - AI-Driven Drug Discovery and Development

Australia - AI-Driven Drug Discovery and Development

Malaysia - AI-Driven Drug Discovery and Development

New Zealand - AI-Driven Drug Discovery and Development

Philippines - AI-Driven Drug Discovery and Development

Singapore - AI-Driven Drug Discovery and Development

Thailand - AI-Driven Drug Discovery and Development

Vietnam - AI-Driven Drug Discovery and Development

India - AI-Driven Drug Discovery and Development

Argentina - AI-Driven Drug Discovery and Development

Chile - AI-Driven Drug Discovery and Development

Costa Rica - AI-Driven Drug Discovery and Development

Ecuador - AI-Driven Drug Discovery and Development

Guatemala - AI-Driven Drug Discovery and Development

Colombia - AI-Driven Drug Discovery and Development

México - AI-Driven Drug Discovery and Development

Panama - AI-Driven Drug Discovery and Development

Peru - AI-Driven Drug Discovery and Development

Uruguay - AI-Driven Drug Discovery and Development

Venezuela - AI-Driven Drug Discovery and Development

Polska - AI-Driven Drug Discovery and Development

United Kingdom - AI-Driven Drug Discovery and Development

South Korea - AI-Driven Drug Discovery and Development

Pakistan - AI-Driven Drug Discovery and Development

Sri Lanka - AI-Driven Drug Discovery and Development

Bulgaria - AI-Driven Drug Discovery and Development

Bolivia - AI-Driven Drug Discovery and Development

Indonesia - AI-Driven Drug Discovery and Development

Kazakhstan - AI-Driven Drug Discovery and Development

Moldova - AI-Driven Drug Discovery and Development

Morocco - AI-Driven Drug Discovery and Development

Tunisia - AI-Driven Drug Discovery and Development

Kuwait - AI-Driven Drug Discovery and Development

Oman - AI-Driven Drug Discovery and Development

Slovakia - AI-Driven Drug Discovery and Development

Kenya - AI-Driven Drug Discovery and Development

Nigeria - AI-Driven Drug Discovery and Development

Botswana - AI-Driven Drug Discovery and Development

Slovenia - AI-Driven Drug Discovery and Development

Croatia - AI-Driven Drug Discovery and Development

Serbia - AI-Driven Drug Discovery and Development

Bhutan - AI-Driven Drug Discovery and Development

Nepal - AI-Driven Drug Discovery and Development

Uzbekistan - AI-Driven Drug Discovery and Development